Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-238.62%
operating margin TTM
-210.76%
revenue TTM
5.31 Million
revenue per share TTM
0.02$
valuation ratios | |
|---|---|
| pe ratio | -2.28 |
| peg ratio | 0.09 |
| price to book ratio | 8.59 |
| price to sales ratio | 5.48 |
| enterprise value multiple | -3.30 |
| price fair value | 8.59 |
profitability ratios | |
|---|---|
| gross profit margin | 15.66% |
| operating profit margin | -210.76% |
| pretax profit margin | -238.04% |
| net profit margin | -238.62% |
| return on assets | -56.77% |
| return on equity | -178.58% |
| return on capital employed | -58.27% |
liquidity ratios | |
|---|---|
| current ratio | 4.89 |
| quick ratio | 4.40 |
| cash ratio | 2.49 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 123.29 |
| operating cycle | 261.36 |
| days of payables outstanding | 5.04 |
| cash conversion cycle | 256.32 |
| receivables turnover | 2.64 |
| payables turnover | 72.45 |
| inventory turnover | 2.96 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.17 |
| debt equity ratio | 1.12 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.53 |
| interest coverage | -5.25 |
| cash flow to debt ratio | -2.70 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.89 |
| cash per share | 0.76 |
| operating cash flow per share | -0.85 |
| free cash flow operating cash flow ratio | 1.05 |
| cash flow coverage ratios | -2.70 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -19.06 |
Frequently Asked Questions
When was the last time Autolus Therapeutics plc (NASDAQ:AUTL) reported earnings?
Autolus Therapeutics plc (AUTL) published its most recent earnings results on 11-08-2026.
What is Autolus Therapeutics plc's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Autolus Therapeutics plc (NASDAQ:AUTL)'s trailing twelve months ROE is -178.58%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Autolus Therapeutics plc (AUTL) currently has a ROA of -56.77%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did AUTL's net profit margin stand at?
AUTL reported a profit margin of -238.62% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is AUTL's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.89 in the most recent quarter. The quick ratio stood at 4.40, with a Debt/Eq ratio of 1.12.

